Stockscreener 앱 받기
5.055
7.59%
-0.415
전일 마감가:
$5.47
열려 있는:
$5.3
하루 거래량:
41,515
Relative Volume:
0.02
시가총액:
$7.49M
수익:
$8.62M
순이익/손실:
$-6.15M
주가수익비율:
-0.4583
EPS:
-11.03
순현금흐름:
$-5.32M
1주 성능:
-7.25%
1개월 성능:
-15.89%
6개월 성능:
+1.30%
1년 성능:
-11.16%
1일 변동 폭
$4.92
$5.446
1주일 범위
$4.92
$5.81
52주 변동 폭
$1.94
$12.32
Evoke Pharma Inc Stock (EVOK) Company Profile
명칭
Evoke Pharma Inc
전화
858-345-1494
주소
420 STEVENS AVENUE, SOLANA BEACH, CA
EVOK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EVOK
Evoke Pharma Inc
|
5.02 | 8.12M | 8.62M | -6.15M | -5.32M | -11.03 |
|
ZTS
Zoetis Inc
|
149.54 | 65.30B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.62 | 45.60B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.5748 | 42.82B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.58 | 18.78B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
299.98 | 13.64B | 2.99B | 1.21B | 1.13B | 25.06 |
Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-06-22 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2019-03-05 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2018-03-08 | 재확인 | B. Riley FBR, Inc. | Buy |
| 2017-10-19 | 재개 | FBR & Co. | Buy |
| 2017-03-16 | 재확인 | Rodman & Renshaw | Buy |
| 2017-01-30 | 업그레이드 | Laidlaw | Neutral → Buy |
| 2017-01-05 | 업그레이드 | Rodman & Renshaw | Neutral → Buy |
| 2016-12-23 | 재확인 | Rodman & Renshaw | Neutral |
| 2016-07-19 | 재확인 | FBR Capital | Outperform |
| 2016-07-19 | 다운그레이드 | Noble Financial | Buy → Hold |
| 2016-07-18 | 다운그레이드 | Rodman & Renshaw | Buy → Neutral |
| 2016-03-16 | 개시 | Northland Capital | Outperform |
| 2016-03-14 | 재확인 | Ascendiant Capital Markets | Buy |
| 2016-02-17 | 재개 | FBR Capital | Outperform |
| 2014-12-03 | 재확인 | MLV & Co | Buy |
| 2014-11-07 | 개시 | MLV & Co | Buy |
| 2014-04-22 | 개시 | Laidlaw | Buy |
| 2013-11-19 | 개시 | Aegis Capital | Buy |
모두보기
Evoke Pharma Inc 주식(EVOK)의 최신 뉴스
Can a trend reversal in Evoke Pharma Inc. lead to recoveryFree Real Market Momentum Signal Generator - Newser
Using RSI to spot recovery in Evoke Pharma Inc.Free High Growth Low Risk Stock Selection - Newser
Tools to monitor Evoke Pharma Inc. recovery probabilityIntelligent Trade Forecast With AI Analytics - Newser
Published on: 2025-08-11 01:03:10 - Newser
Is Evoke Pharma Inc. trending in predictive chart modelsLow Risk Trade Timing with Analysis Metrics - Newser
Is Evoke Pharma Inc. a Top Dividend Stock to Watch in 2025Earnings Based Stock Performance Forecast - Newser
Top Risks to Consider Before Buying Evoke Pharma Inc. StockGrowth Summary Based on Market Positioning - Newser
Will Volume Confirm Reversal in Evoke Pharma Inc.Growth Based Investment Plan Guidance Highlighted - beatles.ru
Using data filters to optimize entry into Evoke Pharma Inc.Triple Digit Gain Opportunity Watchlist - Newser
Evoke Pharma (EVOK) to Release Quarterly Earnings on Tuesday - Defense World
Why Evoke Pharma Inc. stock attracts strong analyst attentionExpert-Backed High Yield Stock Watchlist - Newser
Will Evoke Pharma Inc. stock go up in YEARFastest Growing Stocks to Watch - thegnnews.com
Real time scanner hits for Evoke Pharma Inc. explainedHigh Probability Trade Outcome Prediction - Newser
Evoke Pharma Inc expected to post a loss of 30 cents a shareEarnings Preview - TradingView
Reviewing Sol-Gel Technologies (NASDAQ:SLGL) and Evoke Pharma (NASDAQ:EVOK) - Defense World
Evoke Pharma's GIMOTI Patent Extended to 2038 Through New Patent Issuance - AInvest
Evoke Pharma's GIMOTI Patent Extended To 2038 Following New Patent Issuance - Nasdaq
Evoke Pharma announces issuance of new U.S. patent for GIMOTI - TipRanks
Evoke Pharma Secures New U.S. Patent for GIMOTI® - TipRanks
Evoke Pharma Announces Issuance of New U.S. Patent for GIMOTI Wi - GuruFocus
Evoke Pharma's Extended Market Exclusivity for GIMOTI: A Strategic IP and Regulatory Triumph for Long-Term Growth - AInvest
Evoke Pharma Announces Issuance Of New U.S. Patent For Gimoti With Extended Exclusivity To Late 2038 - TradingView
Evoke Pharma, Inc. Announces New U.S. Patent for GIMOTI® with Extended Market Exclusivity to November 2038 - Quiver Quantitative
Evoke Pharma extends GIMOTI patent protection until 2038 - Investing.com
Evoke Pharma extends GIMOTI patent protection until 2038 By Investing.com - Investing.com Nigeria
GIMOTI Gastroparesis Treatment Secures 2-Year Patent Extension, Strengthening Market Position Through 2038 - Stock Titan
How sentiment analysis helps forecast Evoke Pharma Inc.Stable Profit Zone and Loss Control Analysis - Newser
Applying chart zones and confluence areas to Evoke Pharma Inc.Watchlist Generator for Smart Money Signals - Newser
What makes Evoke Pharma Inc. stock price move sharplyPattern Breakout Prediction for Short Term - Newser
Visualizing Evoke Pharma Inc. stock with heatmapsSecure Buy Strategy Based on Risk Parameters - Newser
Elliott Wave Theory Predicts Pullback in Evoke Pharma Inc.Optimized Watchlist With Daily Adjustments Launched - beatles.ru
How does Evoke Pharma Inc. compare to its industry peersBuild a diversified portfolio for stability - Jammu Links News
What analysts say about Evoke Pharma Inc. stockHigh-octane gains - Jammu Links News
Is it the right time to buy Evoke Pharma Inc. stockMaximize your investment portfolio’s performance - Jammu Links News
When is Evoke Pharma Inc. stock expected to show significant growthExplosive portfolio gains - Jammu Links News
Can momentum traders help lift Evoke Pharma Inc.Technical Confirmation System with Signal Alerts - Newser
How does Evoke Pharma Inc. generate profit in a changing economyBuild wealth faster with expert stock selection - Jammu Links News
How volatile is Evoke Pharma Inc. stock compared to the marketOutperformance with explosive growth - Jammu Links News
What is the dividend policy of Evoke Pharma Inc. stockGet daily updates on market movers and shakers - Jammu Links News
What is the risk reward ratio of investing in Evoke Pharma Inc. stockGain the edge with real-time market data - Jammu Links News
Is Evoke Pharma Inc. a growth stock or a value stockMaximize returns with strategic stock selection - Jammu Links News
Should I hold or sell Evoke Pharma Inc. stock in 2025Free High-Return Strategy Alerts - Jammu Links News
Evoke Pharma, Inc. (NASDAQ:EVOK) Short Interest Update - Defense World
Evoke Pharma Inc (EVOK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.52%
0.20%
자본화:
|
볼륨(24시간):